Friday, 12 February 2016

In The Times today: acerbic Alistair on top form; Helge Lund to head BP

It's a bit late in the day but if you have a copy of the The Times and are planning on having a quiet Friday night in then Alistair's Osborne's business comment column is worth a read. Here is a link if you haven't got a copy:

http://www.thetimes.co.uk/tto/business/columnists/alistairosborne/article4688797.ece

Former Telegraph colleagues might be bit surprised to see me plug Alistair's column as he would regularly tear strips of me in front of my peers.

In fact, he even gave me a ticking off for running the Severn Trent bid story (more on that in a later post) when I bumped into him in Berkeley Square last Autumn - and I don't even work for him anymore.

But the fact is the fact is Alistair really does write a great column, with today's one his best yet. I particularly enjoyed the lead item on Glencore and Rio Tinto. It was incisive, witty and makes valid points. So, too, was the item on Sir Stelios and I'm sure the final line will up the entrepreneur no end (which I suspect is exactly what Alistair intended to do).

The Times people column, edited today by Dom Walsh, also had a juicy nugget suggesting Helge Lund, the outgoing CEO of BG Group, could end up at BP as the new boss...

Canacord Genuity wields the axe - part 2

Canacord Geniuty appears to have tacitly confirmed my tale from earlier in the week.

In case you missed it, the broker/investment bank released dire 3rd quarter results this morning, announcing there would be a major "restructuring" resulting in job losses in the UK and elsewhere.

Thursday, 11 February 2016

Another day, another multi-billion pharma deal - the series returns!

I have to admit I was surprised to see US generic drugs giant Mylan return for Nordic group Meda given the market turbulence and general carnage in biotech share prices.

Hat tip, though, to the Financial Times for landing the scoop last night about the $9.9 billion takeover deal.

Wednesday, 10 February 2016

Canaccord Genuity wields the axe

Here is a tale to add to the doom and gloom that has descended upon financial markets since the beginning of the year.

It would appear there has been a bit of a cull over at Canaccord Genuity, the Canadian stockbroker that has been gobbling up British brokers in the last couple of years.

Tuesday, 9 February 2016

Top of the market? - part 6

I know I should probably reign in the chest beating but global stock markets are down almost 20pc since last spring's highs, so perhaps my "top of the market" series was useful to readers after all.

And I couldn't help but notice that a company that was taken private at the top of the last bull market (i.e in 2007) is floating just as the stock market (potentially) flirts with its the latest "top".

Dobson to retire from FTSE 100-listed Schroders, according to The Times

It never ceases to amazes me how some of the juiciest City tales end up in the diary.

For example, the lead item in The Times City People diary reveals there is a "whisper" Michael Dobson, the veteran Schroders chief executive, is contemplating retirement and may to step down from the blue-chip, blue-blooded fund manager at the next set of figures.

Friday, 5 February 2016

Mega consortium in trouble?

The "mega" consortium chasing London City Airport might be, well, becoming a bit less "mega".

In case you don't recall, the consortium consists of an unusually large amount of constituents, including Borealis, Ontario's Teachers Pension Fund, AimCo, Hermes and Wren House, Kuwait's sovereign wealth fund. Here is a link to Betaville's original scoop on the "mega" consortium and also HNA's bid:

Thursday, 4 February 2016

HSBC takeaway - part 2

Readers might recall that earlier this week HSBC was quick out of the blocks to boast how it was the "sole" financial advisor to ChemChina on its $43 billion purchase of Sygenta, sending out a release on topic in the early hours of Wednesday morning.

Well, it turns out that might not be the case. According to Bloomberg, some chap called Ze'ev Goldberg was never "far from the side" of ChemChina chairman Ren Jianxin during the heated negotiations with Syngenta.

Wednesday, 3 February 2016

Quelle Surprise: Reuters reports Roche approached Pacific Biosciences about a takeover

Reuters has picked up on another one of my Tip TV stories.

Yesterday, the news agency "broke" the story that Swiss pharma giant Roche had approached Pacific Biosciences about a takeover deal. Here is the link:

HSBC takeaway

Ping! An email arrives from HSBC with the headline:

HSBC sole financial advisor to ChemChina on Syngenta acquisition

Tuesday, 2 February 2016

Mega consortium comes together for London City Airport; China's HNA also rumoured to have submitted first round offer - part 4

There is a good story in the Financial Times this evening about British Airways and London City Airport.

BA is threatening to pull out of London City if the airport is sold for more than £2 billion as it could result in higher charges for the airline, according to the Financial Times. Here is the link:

Quelle Surprise: J Sainsbury agrees 161p a share takeover bid for Home Retail Group

I see J Sainsbury and Home Retail Group have effectively agreed a deal that will see the latter taken out for 161p a share by the FTSE 100 company. Here is the link:

http://www.investegate.co.uk/sainsbury-j--plc--sbry-/rns/possible-offer-for-home-retail-group-plc/201602020704437439N/

Sunday, 31 January 2016

Weekend review on Sky, Home Retail Group, J Sainsbury, Slater & Gordon, Royal Dutch Shell and BG Group.

There is plenty to reflect on in the British business press this weekend.

First off, I note that the Financial Times has done a reverse ferret of its position on whether wiley old Rupert Murdoch will have another run at Sky.

Friday, 29 January 2016

Quelle Surprise: Reuters reveals Brookfield is weighing $30 billion takeover of General Growth Properties

I would have done this post earlier but I have been sidetracked by, well, general larking about, including a jolly nice lunch with an old contact at Richard Caring's The Ivy, where I spotted Tory party supremo Lord Feldman chowing down.

Anyway, that's enough of the blatant name dropping. The point of this post is to highlight that Reuters last night picked up on my tip from earlier in the week on Tip TV about US property giant General Growth Properties.

RARE Alert: Reckitt Benckiser said to be working with Robey Warshaw on major deal - part 2

It's good to see little old Betaville's RARE story about Reckitt Benckiser followed up in the British stock market reports this morning.

Just over a month ago I wrote that Reckitt was working with (which is different to formally appointing) uber bankers at Robey Warshaw on a major deal. Here is a link to that piece:

Thursday, 28 January 2016

More GSK rumours from the Twitterati - part 2

Should I be surprised how these random Twitter rumours get out of control? Probably not.

But there are some readers who are now claiming that little old Betaville is reporting Johnson & Johnson is weighing a bid for GlaxoSmithKline.

Burmese Business - part 4

It still never ceases to amaze me how quickly stocks fall in and out of fashion with investors, traders and market participants.

Indeed, the healthcare/ biotech sector has taken another serious pasting today following worse-than-expected figures from Roche, the Swiss pharmaceutical giant. So, AstraZeneca is down 3pc today while Shire has fallen almost 5pc.

More GSK rumours from the Twitterati

Here's an interesting Tweet from Open Outcrier:


Hearing vague takeover chatter mentioning JNJ as acquirer. Unconfirmed market chatter.